Title of article :
Impact of Chronic Obstructive Pulmonary Disease on Valve Academic Research Consortium–Defined Outcomes After Transcatheter Aortic Valve Implantation (from the FRANCE 2 Registry)
Author/Authors :
Chopard، نويسنده , , Romain and Meneveau، نويسنده , , Nicolas and Chocron، نويسنده , , Sidney and Gilard، نويسنده , , Martine and Laskar، نويسنده , , Marc and Eltchaninoff، نويسنده , , Hélène and Iung، نويسنده , , Bernard and Leprince، نويسنده , , Pascal and Teiger، نويسنده , , Emmanuel and Chevreul، نويسنده , , Karine and Prat، نويسنده , , Alain and Lièvre، نويسنده , , Michel and Leguerrier، نويسنده , , Alain and Donzeau-Gouge، نويسنده , , Patrick and Fajadet، نويسنده , , Jean and Schiele، نويسنده , , Francois، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2014
Pages :
7
From page :
1543
To page :
1549
Abstract :
The purposes of the present study were to determine the impact of chronic obstructive pulmonary disease (COPD) on Valve Academic Research Consortium–defined outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). A total of 3,933 consecutive patients underwent TAVI from January 2010 to December 2011 in 34 centers and were included in the French national TAVI registry “FRANCE 2”; 895 (22.7%) had concomitant COPD, 3,038 (77.3%) did not. There were no significant differences in procedural characteristics or 30-day Valve Academic Research Consortium–defined outcomes between those with and without COPD. Multivariate regression analysis showed COPD to be an independent predictor of 1-year mortality and combined efficacy end point after adjustment for concomitant co-morbidities (hazard ratio 1.19, 95% confidence interval 1.005 to 1.41, p = 0.03 and hazard ratio 1.52, 95% confidence interval 1.29 to 1.79, p <0.001, respectively). The higher mortality rate at 1 year in patients with COPD was related to cardiovascular deaths (COPD 10.0% vs non-COPD 6.2%, p = 0.008). Subgroup analysis found that the effect of COPD on 1-year mortality rate was constant across different subgroups, especially the type of approach and the type of anesthesia subgroups. In conclusion, concomitant COPD in patients referred for TAVI characterizes a high-risk population. The excess in mortality is largely determined by a higher rate of cardiovascular deaths and exists regardless of the type of procedure performed and its results.
Journal title :
American Journal of Cardiology
Serial Year :
2014
Journal title :
American Journal of Cardiology
Record number :
1904833
Link To Document :
بازگشت